1-15 of 15
Niels Murawski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Donor Genetic Determinant of Thymopoiesis rs2204985 Impacts Clinical Outcome after Single HLA Mismatched HSCT

Chrysanthi Tsamadou, Sowmya Gowdavally, Uwe Platzbecker, Elisa Sala, Thomas Valerius, Gerald Wulf, Eva Maria Wagner, Nicolaus Kroeger, Niels Murawski, Hermann Einsele, Kerstin Schaefer-Eckart, Sebastian Freitag, Jochen Casper, Martin Kaufmann, Mareike Dürholt, Bernd Hertenstein, Stefan Klein, Mark Ringhoffer, Christine Neuchel, Immanuel Rode, Joannis Mytilineos, Hubert Schrezenmeier, Daniel Fürst
Journal: Blood
Blood (2021) 138 (Supplement 1): 3903.
https://doi.org/10.1182/blood-2021-144748
Published: 2021
Journal Articles

LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcome

Clinical Trials & Observations
Lorenz Thurner, Natalie Fadle, Jörg Thomas Bittenbring, Evi Regitz, Rita Schuck, Onur Cetin, Ariane Stuhr, Torben Rixecker, Niels Murawski, Viola Poeschel, Dominic Kaddu-Mulindwa, Klaus-Dieter Preuss, Stephan Stilgenbauer, Olivier Hermine, Hanneke C. Kluin-Nelemans, Sylvia Hartmann, Martin Dreyling, Christiane Pott, Moritz Bewarder, Eva Hoster
Journal: Blood
Blood (2021) 137 (23): 3251–3258.
https://doi.org/10.1182/blood.2020008835
Published: 2021
Includes: Supplemental data
Journal Articles

Identification and Characterization of CMV-Specific, HLA-C*07:02 Restricted Antibodies

Moritz Bewarder, MD, Gerhard Held, MD, Lorenz Thurner, MD, Klaus Dieter Preuss, PhD, Gabi Carbon, Birgit Bette, Konstantinos Christofyllakis, MD, Arne Felbel, Dominic Kaddu-Mulindwa, MD, Niels Murawski, MD, Stephan Stilgenbauer, Frank Neumann, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5616.
https://doi.org/10.1182/blood-2019-126998
Published: 2019
Journal Articles

Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA

Viola Poeschel, MD, Gerhard Held, MD, Marita Ziepert, PhD, Bettina Altmann, PhD, Mathias Witzens-Harig, MD, Harald Holte, MD PhD, Lorenz Thurner, MD, Andreas Viardot, MD, Peter Borchmann, MD, Lothar Kanz, Ulrich Keller, Christian Schmidt, MD, Rolf Mahlberg, MD, Bernd Metzner, MDPhD, Reinhard Marks, Heinz-Gert Hoeffkes, MD, Konstantinos Christofyllakis, MD, Josif Amam, Christian Berdel, MD, Stephan Stilgenbauer, Norbert Schmitz, MD, Lorenz Truemper, MD, Niels Murawski, MD, Markus Loeffler, MD, Michael Pfreundschuh, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 781.
https://doi.org/10.1182/blood-2018-99-112403
Published: 2018
Journal Articles

Excellent Outcome of Elderly Patients with Favourable-Prognosis DLBCL Treated with 4 Cycles CHOP/Chlip-14 Plus 8 Applications of Rituximab and a PET-Based Intensification Strategy That Includes Involved-Site Radiotherapy (IS-RT): Results of the First 120 Patients of the OPTIMAL>60 Trial of the Dshnhl

Michael Pfreundschuh, MD, Niels Murawski, MD, Konstantinos Christofyllakis, Bettina Altmann, Marita Ziepert, PhD, Mathias Haenel, MD, Andreas Viardot, MD, Andreas Neubauer, MD, Gerhard Held, MD, Lorenz Truemper, Christian Schmidt, MD, Lothar Kanz, Kai Huebel, MD, Norbert Schmitz, MD, Tobias Heintges, MD, Heinz Kirchen, MD, Günther Schneider, MD, Christian Ruebe, MD, Christian Berdel, MD, Dirk Hellwig, MD, Jirka Grosse, MD, Viola Poeschel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1549.
https://doi.org/10.1182/blood.V130.Suppl_1.1549.1549
Published: 2017
Journal Articles

Liposomal Formulation of Vincristine Allows for Doubling the Dose Compared to Conventional Vincristine: Results of the First Futility Analysis of the OPTIMAL>60 Study of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

Sascha Duecker, Viola Poeschel, Anne Wolf, MD, Gerhard Held, MD, Niels Murawski, MD, Carsten Zwick, MD, Mathias Haenel, MD, Andreas Viardot, Lorenz H. Truemper, MD PhD, Marita Ziepert, Michael Pfreundschuh
Journal: Blood
Blood (2014) 124 (21): 4420.
https://doi.org/10.1182/blood.V124.21.4420.4420
Published: 2014
Journal Articles

The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas

Clinical Trials & Observations
Niels Murawski, Gerhard Held, Marita Ziepert, Barbara Kempf, Andreas Viardot, Mathias Hänel, Mathias Witzens-Harig, Rolf Mahlberg, Christian Rübe, Jochen Fleckenstein, Carsten Zwick, Bertram Glass, Norbert Schmitz, Samira Zeynalova, Michael Pfreundschuh
Journal: Blood
Blood (2014) 124 (5): 720–728.
https://doi.org/10.1182/blood-2013-10-535021
Published: 2014
Includes: Supplemental data
Journal Articles

Suboptimal dosing of rituximab in male and female patients with DLBCL

Clinical Trials & Observations
Michael Pfreundschuh, Carsten Müller, Samira Zeynalova, Evelyn Kuhnt, Martin H. J. Wiesen, Gerhard Held, Tanja Rixecker, Viola Poeschel, Carsten Zwick, Marcel Reiser, Norbert Schmitz, Niels Murawski
Journal: Blood
Blood (2014) 123 (5): 640–646.
https://doi.org/10.1182/blood-2013-07-517037
Published: 2014
Includes: Supplemental data
Journal Articles

The Impact of Rituximab and Radiotherapy On Treatment Outcome of Patients with DLBCL and Skeletal Involvement

Gerhard Held, MD, Samira Zeynalova, PhD, Niels Murawski, MD, Marita Ziepert, PhD, Barbara Kempf, MD, Andreas Viardot, MD, Martin Dreyling, Michael Hallek, MD, Mathias Witzens-Harig, MD, Christian Ruebe, MD, Christian Berdel, MD, Carsten Zwick, MD, Norbert Schmitz, MD, Michael Pfreundschuh, MD
Journal: Blood
Blood (2012) 120 (21): 690.
https://doi.org/10.1182/blood.V120.21.690.690
Published: 2012
Journal Articles

The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL

Clinical Trials & Observations
Carsten Müller, Niels Murawski, Martin H. J. Wiesen, Gerhard Held, Viola Poeschel, Samira Zeynalova, Michael Wenger, Christina Nickenig, Norma Peter, Eva Lengfelder, Bernd Metzner, Tanja Rixecker, Carsten Zwick, Michael Pfreundschuh, Marcel Reiser
Journal: Blood
Blood (2012) 119 (14): 3276–3284.
https://doi.org/10.1182/blood-2011-09-380949
Published: 2012
Journal Articles

Improved Outcome of Elderly Poor-Prognosis DLBCL Patients with 6xCHOP-14 and 8 Applications of Rituximab (R) Given Over An Extended Period: Results of the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

Michael Pfreundschuh, MD, Gerhard Held, Samira Zeynalova, Viola Pöschel, Andreas Viardot, MD, Matthias Hänel, MD, Ulrich Keller, MD, Marcel Reiser, MD, Markus Löffler, Niels Murawski, MD
Journal: Blood
Blood (2011) 118 (21): 592.
https://doi.org/10.1182/blood.V118.21.592.592
Published: 2011
Journal Articles

Randomised Intergroup Trial of First line Treatment for young Low-Risk Patients (<61 years) with Diffuse Large B-Cell Non-Hodgkin's Lymphoma (DLBCL) with a CHOP-like Regimen with or without the Anti-CD20 Antibody Rituximab – 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group

Michael Pfreundschuh, MD, Evelyn Kuhnt, Lorenz Trümper, MD, Anders Osterborg, MD, PhD, Marek Trneny, MD, Lois Shepherd, MD, Devinder S Gill, MD, Jan Walewski, MD, Ruth Pettengell, FRACP, PhD, Ulrich Jäger, MD, Pier Luigi Zinzani, MD, PhD, Ofer Shpilberg, MD, MPH, Stein Kvaloy, MD, Mads Hansen, MD, Rolf Stahel, MD, Noel Milpied, MD, Armando Lopez-Guillermo, MD, Sandra Grass, MD, Niels Murawski, MD, Viola Pöschel, Markus Löffler
Journal: Blood
Blood (2010) 116 (21): 111.
https://doi.org/10.1182/blood.V116.21.111.111
Published: 2010
Journal Articles

The Role of the Rituximab Partner Chemotherapy Regimen In Young Patients with Good-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of the 6-Year Follow-up of the Mint Study of the Mabthera International Trial (MInT) Group.

Niels Murawski, MD, Evelyn Kuhnt, Sandra Grass, MD, Wolfgang Hiddemann, MD, Eva Cavallin-Stahl, MD, Georg Hess, MD, Mathias Witzens-Harig, Ingrid Vasova, MD, Ulrich Jäger, MD, Michal Osowiecki, MD, Scott North, MD, Ruth Pettengell, FRACP, PhD, Viola Pöschel, Markus Löffler, Michael Pfreundschuh, MD
Journal: Blood
Blood (2010) 116 (21): 2826.
https://doi.org/10.1182/blood.V116.21.2826.2826
Published: 2010
Journal Articles

Male Sex Is Associated with Lower Rituximab Trough Serum Levels and Evolves as a Significant Prognostic Factor in Elderly Patients with DLBCL Treated with R-CHOP: Results From 4 Prospective Trials of the German High-Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, Niels Murawski, Samira Zeynalova, Viola Poeschel, Marcel Reiser, Anthony D. Ho, Christina Nickenig, Swen Wessendorf, Bernd Metzner, Sandra Grass, Joerg Schubert, Markus Loeffler, Norbert Schmitz
Journal: Blood
Blood (2009) 114 (22): 3715.
https://doi.org/10.1182/blood.V114.22.3715.3715
Published: 2009
Journal Articles

Hyperphosphorylated Paratarg-7 Is a Frequent Antigenic Target of IgM Paraproteins, Is Dominantly Inherited and Represents a Highly Significant Risk Factor for Monoclonal Gammopathy of Undetermined Significance of the IgM Type (IgM-MGUS) and Waldenstrom's Macroglobulinemia (WM), Allowing for the Identification of Family Members at Risk in Cases of Familial IgM-MGUS and WM.

Sandra Grass, Klaus-Dieter Preuss, Alexandra Wikowicz, Evangelos Terpos, Marita Ziepert, Manfred Ahlgrimm, Natalie Fadle, Evi Regitz, Niels Murawski, Meletios A. Dimopoulos, Steven P. Treon, MD, PhD, Zachary Hunter, Michael Pfreundschuh
Journal: Blood
Blood (2009) 114 (22): 3935.
https://doi.org/10.1182/blood.V114.22.3935.3935
Published: 2009